Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy

Completed · Phase 4

Conditions studied: Wound Infection

In brief

This randomized prospective study will specifically investigate the efficacy of a 24 hour post-operative course of broad-spectrum prophylactic antibiotics - namely Cefazolin - in preventing wound infection and wound breakdown following vulvectomy.

Key facts

Study ID

NCT00550290

Run by

Aultman Health Foundation

People needed

18

Starts

2007-10-01

Expected to finish

2009-04-01

Last updated by the study team

2018-10-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All female patients 18 years of age or older undergoing surgery for vulvar carcinoma (this includes female patients undergoing any form of vulvectomy - radical, vulvectomy without groin node dissection, and partial vulvectomy)
• Disease State will not affect inclusion in the study. Women with previous surgery for vulvar carcinoma will be included as will those undergoing initial operation.
• Number of subjects: 160

You may not qualify if…

• Women simultaneously undergoing treatment for other forms of cancer
• Women under the age of 18
• Pregnant patients

Where it is running

• Aultman Health Foundation — Canton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.